| Name | strophanthidin |
|---|---|
| Synonyms |
3-beta,5,14-trioxy-19-oxo-digen-(20:22)-olid
corchsulin 3-beta,5,14-trihydroxy-19-oxo-5-beta-cd-20-enolid 3-beta,5,14-trihydroxy-19-oxo-5-beta-cd-20-enolide Strophanthidine-RM CYMIGENEN STROPHANTHIDIN K antibioticxs-89 nsc-86078 20-cdenolide Cd-20(22)-enolide,3,5,14-trihydroxy-19-oxo-, (3b,5b) 3,5,14-trihydroxy-19-oxocd-20-enolide 5BETA,20-CDENOLIDE-19-ONE-3BETA,5,14-TRIOL corchorgenin Corchorogenin (3S,5S,8R,9S,10S,13R,14S,17R)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-cbaldehyde Convallatoxigenin MFCD00046266 Strophantidin Cd-20(22)-enolide, 3,5,14-trihydroxy-19-oxo-, (3β,5β) Corchoside A aglycon 5-beta-hydroxy-19-oxodigitoxigenin Corchsularin cynotoxin corchosideaaglycon Strophanthidine Strophanthidin, 10 mM in DMSO Erysimupicrone Strophanthidin,3β,5,14-Trihydroxy-19-oxo-5β,20-cdenolide, Cymigenen, K-Strophanthidin Strophanthidin Corchorgenin convallatoxigenin k-strophanthidine EINECS 200-626-6 (3S,5S,8R,9S,10S,13R,14S,17R)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde strophanthidine STIGMASTANOL(SH) 3β5,14-Trihydroxy-19-oxo-5β20-cdenolide corchorin erysimupikron apocynamin 3BETA,5,14-TRIHYDROXY-19-OXO-5BETA,20-CDENOLIDE Strophanthidin K 3β,5,14-Trihydroxy-19-oxo-5β cymigenin 19-oxo-cdogenen-(20:22)-triol-(3-beta,5,14) 3-beta,5,14-trioxy-19-oxo-cden-(20:22)-olid k-Strophanthidin K-STROPHANTHIDIN erysimupicrone Corcholin 3,5,14-trihydroxy-19-oxo-,(3-beta,5-beta)-cd-20-enolid (3S,5S,8R,9S,10S,13R,14S,17R)-3,5,14-trihydroxy-17-(5-keto-2H-furan-3-yl)-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-cbaldehyde Apocymin cyanotoxin Sodium potassium pump,Na+/K+ ATPase,cdiac,naturally,available,systolic,glycoside,diastolic,Strophanthidin,inhibit,scolemmal,Inhibitor 3β,5,14-Trihydroxy-19-oxo-5β,20-cdenolide, Cymigenen, K-Strophanthidin Corchotoxin (3beta,5beta)-3,5,14-trihydroxy-19-oxocd-20-enolide Corchorin |
| Description | Strophanthidin is a naturally available cardiac glycoside[1]. Strophanthidin 0.1 and 1 nmol/L increases and 1~100 µmol/L inhibits the Na+/K+-ATPase activities, but Strophanthidin 10 and 100 nmol/L does not affect Na+/K+-ATPase activities in cardiac sarcolemmal[2]. Strophanthidin increases both diastolic and systolic intracellular Ca2+ concentration[3]. |
|---|---|
| Related Catalog | |
| Target |
Na+/K+-ATPase[2] |
| In Vitro | Strophanthidin (0~10 μM; 24 hours; MCF-7, A549, and HepG2 cells) is effective at suppressing the growth of cancer cells and has no toxicity in normal cells[1]. Strophanthidin (0.5 to 500 µM; PBMCs) does not show significant cytotoxicity in PBMCs. Strophanthidin (2 µM; MCF-7 cells) can arrest cell cycle at the G2/M phase[1]. Strophanthidin (MCF-7, A549, and HepG2 cells) is effective at suppressing the growth of cancer cells and has no toxicity in normal cells. Strophanthidin (MCF-7, A549, and HepG2 cells) inhibits the expression of checkpoint and cyclin-dependent kinases in three cancer cells compared to untreated controls. Strophanthidin can modulate the protein localization from the nucleus to the membrane as well as to the cytoplasm. Strophanthidin is a monosaccharide cardiac glycoside with one aglycone portion and without any sugar unit. Strophanthidin induces apoptosis by the attenuation of multiple biochemical signaling pathways and by arresting cell cycle at the G2/M phase through p53-dependent and p53-independent mechanisms[1]. Cell Viability Assay[1] Cell Line: MCF-7, A549, and HepG2 cells Concentration: 0~10 μM Incubation Time: 24 hours Result: Inhibited the proliferation in three different cancer cells. |
| References |
| Density | 1.432 g/cm3 |
|---|---|
| Boiling Point | 620.7ºC at 760 mmHg |
| Melting Point | 169ºC |
| Molecular Formula | C23H32O6 |
| Molecular Weight | 404.49700 |
| Flash Point | 214.9ºC |
| Exact Mass | 404.22000 |
| PSA | 104.06000 |
| LogP | 1.89820 |
| Index of Refraction | 1.674 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS06 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H300-H310-H330 |
| Precautionary Statements | P260-P264-P280-P284-P302 + P350-P310 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| Hazard Codes | T+: Very toxic; |
| Risk Phrases | R26/27/28 |
| Safety Phrases | S22;S36/S37/S39;S45 |
| RIDADR | UN 2811 6 |
| RTECS | FH5425000 |
|
~82%
66-28-4 |
| Literature: Makarevich, I. F.; Tishchenko, A. A.; Terno, I. S. Chemistry of Natural Compounds, 1991 , vol. 27, # 1 p. 53 - 55 Khimiya Prirodnykh Soedinenii, 1991 , # 1 p. 62 - 64 |
|
~%
Detail
|
| Literature: Chemistry of Natural Compounds, , vol. 22, # 2 p. 186 - 189 Khimiya Prirodnykh Soedinenii, , vol. 22, # 2 p. 201 - 204 |
|
~%
66-28-4 |
| Literature: Gazzetta Chimica Italiana, , vol. 112, # 9/10 p. 349 - 352 |
| Precursor 3 | |
|---|---|
| DownStream 4 | |